Erschienen in:
03.11.2020 | ASO Author Reflections
ASO Author Reflections: Palliative Chemotherapy for Upper Gastrointestinal Cancer: Balancing Hope, Reality, Survival, and Symptoms
verfasst von:
Shaila J. Merchant, MSc, MHSc, MD, Christopher M. Booth, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 1/2021
Einloggen, um Zugang zu erhalten
Excerpt
Palliative chemotherapy (PC) is associated with a modest survival benefit in patients with incurable esophageal and gastric cancer; however, changes in symptom profile during treatment are not well described, particularly in patients seen in routine practice. Understanding the trajectory of symptoms during treatment may lead to improved patient–provider discussions surrounding the initiation of PC. In the current study, we describe changes in patient-reported symptoms during PC. Symptoms were assessed using the Edmonton Symptom Assessment System (ESAS), a validated screening tool developed to assist healthcare providers in the assessment of nine symptoms commonly observed in patients with cancer, including pain, tiredness, drowsiness, nausea, lack of appetite, depression, anxiety, shortness of breath, and lack of well-being.
1, 2 …